Aspirin and arm cuff therapy for mild moyamoya disease
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a daily aspirin regimen combined with a blood-pressure cuff treatment on the arm can slow the progression of mild moyamoya disease. It aims to reduce the risk of strokes and bleeding events.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of mild moyamoya disease.
- You cannot have had any bleeding inside the skull, a stroke with symptoms, frequent transient ischemic attacks (TIAs), or seizures before joining.
- You must not have other brain conditions like aneurysms, arteriovenous malformations, or a history of brain surgery or radiation.
- You must be willing to take aspirin daily and undergo the arm cuff therapy, and not be allergic or have contraindications to aspirin.
- You must not have severe heart, liver, or kidney problems, and not currently require anticoagulant (blood-thinning) medications.
- You cannot be pregnant or breastfeeding, and must not be in another interventional trial.
- You must be able to attend follow-up visits and follow instructions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial follows people with moyamoya disease who are treated with medication only, and it also looks at first-degree relatives. The goal is to understand long-term outcomes and whether careful conservative care is beneficial over time.
This study tests if statins (cholesterol-lowering drugs) can help people with Moyamoya disease. The trial will follow patients who receive either surgery or standard care to see if adding a statin improves outcomes.
This trial studies whether a treatment called RIC (remote ischemic conditioning) is safe and helpful for children with moyamoya disease who undergo revascularization surgery. It aims to improve outcomes after surgery and reduce risk, while carefully tracking safety.
This study looks at why some people with moyamoya disease have trouble with thinking and memory. It may help find better ways to understand and treat these problems.
This study is building a tool to predict how people with moyamoya disease will do after brain surgery to improve blood flow. If you are an adult with moyamoya and are scheduled for this surgery, you may be able to help.
This study looks at how Moyamoya disease changes over time and what predicts outcomes. It uses approved brain imaging and, likely, thinking/memory tests to understand prognosis.
Hear when a new Moyamoya Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.